Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
NCT05966467
·
clinicaltrials.gov ↗
RECRUITING
Status
122
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuromyelitis Optica Spectrum Disorder
NMOSD
AQP4+ NMOSD
Sponsor
Alexion Pharmaceuticals, Inc.